Ionis Pharmaceuticals, Inc. (IONS)
USD 36.25
(-3.8%)
USD 36.25
(-3.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 787.64 Million | 587 Million | 810 Million | 729 Million | 1.12 Billion | 599.67 Million |
| Cost of Revenue | 9.13 Million | 14 Million | 11 Million | 12 Million | 4 Million | 1.82 Million |
| Gross Profit | 778.51 Million | 573 Million | 799 Million | 717 Million | 1.11 Billion | 597.85 Million |
| Operating Expenses | 779.58 Million | 984 Million | 829 Million | 889 Million | 753 Million | 659.22 Million |
| Selling, General and Administrative Expenses | 232.6 Million | 151 Million | 186 Million | 354 Million | 287 Million | 244.62 Million |
| Research and Development Expenses | 899.62 Million | 833 Million | 643 Million | 535 Million | 466 Million | 414.6 Million |
| Other Expenses | 19 Thousand | 3 Million | 9 Million | 2 Million | -686 Thousand | -182 Thousand |
| Cost and Expenses | 1.14 Billion | 998 Million | 840 Million | 901 Million | 757 Million | 661.04 Million |
| Operating Income | -353.73 Million | -411 Million | -30 Million | -172 Million | 366 Million | -61.37 Million |
| Interest Expense | - | 8.12 Million | 4.3 Million | 44.99 Million | 49 Million | 44.78 Million |
| Income Tax Expense | 32.32 Million | 12 Million | -1 Million | 317 Million | 44 Million | -291.14 Million |
| Earnings before Tax | -333.96 Million | -258 Million | -30 Million | -170 Million | 347 Million | -76.15 Million |
| Net Income | -366.28 Million | -270 Million | -29 Million | -487 Million | 294 Million | 273.74 Million |
| Earnings Per Share Basic | -2.56 | -1.90 | -0.21 | -3.49 | 2.10 | 2.07 |
| Earnings Per Share Diluted | -2.56 | -1.90 | -0.21 | -3.49 | 2.06 | 2.04 |
| Weighted Average Shares Outstanding | 143.19 Million | 141.84 Million | 141.02 Million | 139.61 Million | 139.99 Million | 132.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 143.19 Million | 141.84 Million | 141.02 Million | 139.61 Million | 142.87 Million | 134.05 Million |
| Gross Margin | 0.99 | 0.98 | 0.99 | 0.98 | 1.00 | 1.00 |
| EBIT Margin | -0.29 | -0.96 | -0.03 | -0.24 | 0.33 | -0.10 |
| Profit Margin | -0.47 | -0.46 | -0.04 | -0.67 | 0.26 | 0.46 |
| EBITDA | -230.01 Million | -227.75 Million | -239 Thousand | -107.88 Million | 411.53 Million | -18.83 Million |
| Earnings Before Tax Margin | -0.45 | -0.70 | -0.04 | -0.24 | 0.33 | -0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 225.25 Million | 119.49 Million | 324.5 Million | 787.64 Million | 144 Million | 188 Million |
| Cost of Revenue | 9.74 Million | 7.8 Million | 3.06 Million | 9.13 Million | 2 Million | 3 Million |
| Gross Profit | 215.5 Million | 111.69 Million | 321.44 Million | 778.51 Million | 142 Million | 185 Million |
| Operating Expenses | 281.59 Million | 261.2 Million | 327.55 Million | 1.13 Billion | 285 Million | 276 Million |
| Selling, General and Administrative Expenses | 59.53 Million | 46.99 Million | 71 Million | - | 70 Million | 46 Million |
| Research and Development Expenses | 222.06 Million | 214.21 Million | 256.55 Million | - | 215 Million | 230 Million |
| Other Expenses | 610 Thousand | 277 Thousand | 399 Thousand | 14.25 Million | 20 Million | 32 Million |
| Cost and Expenses | 291.34 Million | 269.01 Million | 330.61 Million | 1.14 Billion | 287 Million | 279 Million |
| Operating Income | -66.09 Million | -149.51 Million | -6.12 Million | -353.73 Million | -143 Million | -91 Million |
| Interest Expense | 22.78 Million | 20.55 Million | 20.84 Million | 75.59 Million | 18 Million | 18 Million |
| Income Tax Expense | 64 Thousand | 75 Thousand | 6.49 Million | 32.32 Million | 6 Million | 8 Million |
| Earnings before Tax | -66.2 Million | -142.72 Million | -2.76 Million | -333.96 Million | -141 Million | -77 Million |
| Net Income | -66.26 Million | -142.8 Million | -9.26 Million | -366.28 Million | -147 Million | -85 Million |
| Earnings Per Share Basic | -0.45 | -0.98 | -0.06 | - | -1.03 | -0.59 |
| Earnings Per Share Diluted | -0.45 | -0.98 | -0.06 | - | -1.03 | -0.59 |
| Weighted Average Shares Outstanding | 145.95 Million | 145.53 Million | 144 Million | 143.19 Million | 143.31 Million | 143.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 145.95 Million | 145.53 Million | 144 Million | 143.19 Million | 143.31 Million | 143.09 Million |
| Gross Margin | 0.96 | 0.93 | 0.99 | 0.99 | 0.99 | 0.98 |
| EBIT Margin | -0.27 | -1.20 | -0.01 | - | -0.85 | -0.31 |
| Profit Margin | -0.29 | -1.20 | -0.03 | -0.47 | -1.02 | -0.45 |
| EBITDA | -60.51 Million | -143.86 Million | -1.67 Million | - | -123 Million | -59 Million |
| Earnings Before Tax Margin | -0.29 | -1.25 | -0.02 | -0.45 | -0.99 | -0.48 |
0113
6503
0574
VSTKF
0008
0KBK